^
    Back
    Association details:
    Biomarker:No biomarker
    Cancer:Gastroesophageal Junction Adenocarcinoma
    Drug:cisplatin (DNA synthesis inhibitor) +
    docetaxel (Tubulin polymerization promoter, Microtubule stabilizer) +
    5-fluorouracil (Thymidylate synthase inhibitor)
    Direction:Sensitive
    Evidence:
    Evidence Level:
    Sensitive: A1 - Approval
    Source:
    FDA
    Published date:
    01/13/2021
    Excerpt:
    Docetaxel Injection is a microtubule inhibitor indicated for...Gastric Adenocarcinoma (GC): with cisplatin and fluorouracil for untreated, advanced GC, including the gastroesophageal junction